Mazarakis, Nadia
Vongsvivut, Jitraporn
Bambery, Keith R.
Ververis, Katherine
Tobin, Mark J.
Royce, Simon G.
Samuel, Chrishan S.
Snibson, Kenneth J.
Licciardi, Paul V.
Karagiannis, Tom C.
Funding for this research was provided by:
Australian Government Research Training Program
Australian Nuclear Science and Technology Organisation
McCord Research
Article History
Received: 25 October 2019
Accepted: 29 June 2020
First Online: 16 July 2020
Competing interests
: Epigenomic Medicine Laboratory (Central Clinical School, Monash University) (TCK) is in part supported financially by McCord Research (Iowa, USA), which has a commercial interest in sulforaphane. PVL, KRB, MJT, KV, JV, SGR, CSS, KJS and NM have no competing interests.